A national drug survey of U.S. adolescents and adults found that psychedelic use among young adults has reached its highest levels since 1982.
As psychedelic-assisted therapies enter the medical and pharmaceutical mainstream, some scientists are pushing back against a mystical mindset that permeates much of this growing movement.
The results suggest that despite differences in pharmacology, there may be a role for cannabis in the emerging psychedelic therapy paradigm alongside tryptamine psychedelics.
Following its decriminalization of psilocybin, the city will educate and support police departments, fire departments, paramedics and more to help citizens experiencing a challenging time with psychedelics.
A new review paper finds that most potential psychiatric drug and psychedelics combinations pose mild to modest risks – but the exceptions, which can be serious, are important to understand.
A new study with mice suggests that ketamine and exposure to flickering light can restore the neural plasticity of childhood.
Evidence suggests that psychedelics may lead to long-lasting improvements in overall wellness due to positive behavior changes.
Surprising findings in a new study suggest the common anesthetic and sometimes club drug might also make teens more resilient to stress-induced depression after treatment.
An innovative study finds that ayahuasca impacts the expression of DNA, illuminating what makes ayahuasca so therapeutic.
Western classical music is the the go-to for clinical psychedelic experiences, but a new study suggests it may be less effective than other genres, like overtone-based music.